Morrell Martha, Chief Medical Officer of NeuroPace Inc. ($NPCE), made one open market sale of common shares in the last 365 days, totaling $399,250. Her most recent NPCE insider sale occurred on December 15, 2025. Among 11,678 insiders with open market sales, her activity ranks 6,952nd by value, well below the average of $8.6 million per person across about 6.4 transactions. She reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 24, 2026 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 1341 | $13.27 | 47,283.0000 | 33,307,734 | 2.76% | 0.00% |
| March 3, 2026 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 1340 | $13.83 | 48,624.0000 | 33,307,734 | 2.68% | 0.00% |
| Dec. 15, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | S | Common Stock | 25000 | $15.97 | 49,964.0000 | 33,307,734 | 33.35% | 0.08% |
| Feb. 27, 2026 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 358 | $14.58 | 74,964.0000 | 33,307,734 | 0.48% | 0.00% |
| Feb. 20, 2026 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 3412 | $14.34 | 75,322.0000 | 33,307,734 | 4.33% | 0.01% |
| Dec. 3, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 1338 | $16.66 | 78,734.0000 | 33,307,734 | 1.67% | 0.00% |
| Nov. 27, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 357 | $16.50 | 80,072.0000 | 33,307,734 | 0.44% | 0.00% |
| Nov. 20, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 3051 | $13.50 | 80,429.0000 | 33,307,734 | 3.65% | 0.01% |
| Sept. 3, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 1337 | $9.36 | 83,480.0000 | 32,560,130 | 1.58% | 0.00% |
| Aug. 27, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 357 | $8.88 | 84,817.0000 | 32,560,130 | 0.42% | 0.00% |
| Aug. 20, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 3052 | $8.66 | 85,174.0000 | 32,560,130 | 3.46% | 0.01% |
| June 3, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 1338 | $13.54 | 85,943.0000 | 32,560,130 | 1.53% | 0.00% |
| May 27, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 357 | $12.66 | 87,281.0000 | 32,560,130 | 0.41% | 0.00% |
| May 20, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 3051 | $17.99 | 87,638.0000 | 32,560,130 | 3.36% | 0.01% |
| April 22, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 237 | $10.94 | 90,689.0000 | 32,560,130 | 0.26% | 0.00% |
| March 24, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | A | Common Stock | 11700 | $0.00 | 90,926.0000 | 32,560,130 | 14.77% | 0.04% |
| March 24, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 19850 | $0.00 | 19,850.0000 | 32,560,130 | 9999.99% | 0.06% |
| March 3, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 1337 | $11.81 | 79,226.0000 | 32,560,130 | 1.66% | 0.00% |
| Feb. 27, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 1430 | $12.56 | 80,563.0000 | 0 | 1.74% | 0.00% |
| May 20, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 3045 | $7.98 | 57,986.0000 | 0 | 4.99% | 0.00% |
| June 3, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 1335 | $6.46 | 56,511.0000 | 0 | 2.31% | 0.00% |
| July 22, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 237 | $7.65 | 56,414.0000 | 0 | 0.42% | 0.00% |
| Aug. 20, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 3045 | $7.24 | 53,369.0000 | 0 | 5.40% | 0.00% |
| Sept. 3, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 1334 | $7.39 | 52,035.0000 | 0 | 2.50% | 0.00% |
| Oct. 22, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 237 | $6.00 | 51,798.0000 | 0 | 0.46% | 0.00% |
| Nov. 20, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 3045 | $9.19 | 48,753.0000 | 0 | 5.88% | 0.00% |
| Dec. 3, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 1413 | $11.93 | 47,340.0000 | 0 | 2.90% | 0.00% |
| Jan. 22, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 265 | $14.04 | 47,075.0000 | 0 | 0.56% | 0.00% |
| Feb. 20, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 3405 | $14.23 | 43,670.0000 | 0 | 7.23% | 0.00% |
| Jan. 31, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | M | Common Stock | 192 | $0.03 | 43,862.0000 | 0 | 0.44% | 0.00% |
| Jan. 31, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | M | Common Stock | 192 | $0.03 | 44,054.0000 | 0 | 0.44% | 0.00% |
| Jan. 31, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | M | Common stock | 192 | $0.03 | 44,246.0000 | 0 | 0.44% | 0.00% |
| Jan. 31, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | M | Common Stock | 12234 | $0.03 | 56,480.0000 | 0 | 27.65% | 0.00% |
| Jan. 31, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | M | Common Stock | 40000 | $0.03 | 96,480.0000 | 0 | 70.82% | 0.00% |
| Jan. 31, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | M | Stock Option (Rt to Buy) | 192 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 31, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | M | Stock Option (Rt to Buy) | 192 | $0.00 | 192.0000 | 0 | 50.00% | 0.00% |
| Jan. 31, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | M | Stock Option (Rt to Buy) | 12234 | $0.00 | 12,234.0000 | 0 | 50.00% | 0.00% |
| Jan. 31, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | M | Stock Option (Rt to Buy) | 40000 | $0.00 | 180,449.0000 | 0 | 18.14% | 0.00% |
| Jan. 31, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | M | Stock Option (Rt to Buy) | 192 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 21, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | S | Common Stock | 78334 | $13.72 | 81,993.0000 | 0 | 48.86% | 0.00% |
| Feb. 12, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | M | Common Stock | 50000 | $0.03 | 160,327.0000 | 0 | 45.32% | 0.00% |
| Feb. 12, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | M | Stock Option (Rt to Buy) | 50000 | $0.00 | 140,449.0000 | 0 | 26.25% | 0.00% |
| April 22, 2022 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 926 | $8.32 | 85,836.0000 | 0 | 1.07% | 0.00% |
| July 22, 2022 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 231 | $5.55 | 85,605.0000 | 0 | 0.27% | 0.00% |
| Oct. 22, 2022 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 233 | $3.02 | 85,372.0000 | 0 | 0.27% | 0.00% |
| Jan. 22, 2023 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 264 | $2.98 | 85,108.0000 | 0 | 0.31% | 0.00% |
| March 3, 2023 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 5167 | $4.10 | 79,941.0000 | 0 | 6.07% | 0.00% |
| April 22, 2023 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 231 | $4.25 | 79,710.0000 | 0 | 0.29% | 0.00% |
| June 3, 2023 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 1303 | $4.11 | 78,407.0000 | 0 | 1.63% | 0.00% |
| July 22, 2023 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 231 | $4.13 | 78,176.0000 | 0 | 0.29% | 0.00% |
| Sept. 3, 2023 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 1302 | $8.93 | 76,874.0000 | 0 | 1.67% | 0.00% |
| Oct. 22, 2023 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 231 | $6.88 | 76,643.0000 | 0 | 0.30% | 0.00% |
| Dec. 3, 2023 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 1303 | $8.90 | 75,340.0000 | 0 | 1.70% | 0.00% |
| Jan. 22, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 264 | $14.84 | 75,076.0000 | 0 | 0.35% | 0.00% |
| Feb. 20, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 12474 | $17.50 | 62,602.0000 | 0 | 16.62% | 0.00% |
| March 3, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 1334 | $15.99 | 61,031.0000 | 0 | 2.14% | 0.00% |
| April 22, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | F | Common Stock | 237 | $14.00 | 61,268.0000 | 0 | 0.39% | 0.00% |
| Jan. 29, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | S | Common Stock | 100 | $15.00 | 86,962.0000 | 0 | 0.11% | 0.00% |
| Jan. 30, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | S | Common Stock | 200 | $15.00 | 86,762.0000 | 0 | 0.23% | 0.00% |
| Jan. 24, 2025 | NeuroPace Inc | $NPCE | Morrell Martha | CHIEF MEDICAL OFFICER | S | Common Stock | 3200 | $15.01 | 87,062.0000 | 0 | 3.55% | 0.00% |
| Feb. 27, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | Chief Medical Officer | A | Stock Option (Right to Buy) | 24950 | $0.00 | 24,950.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | Chief Medical Officer | A | Common Stock | 12500 | $0.00 | 90,262.0000 | 0 | 16.07% | 0.00% |
| Feb. 2, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | Chief Medical Officer | S | Common Stock | 14143 | $15.07 | 81,208.0000 | 0 | 14.83% | 0.00% |
| Feb. 5, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | Chief Medical Officer | S | Common Stock | 3446 | $15.17 | 77,762.0000 | 0 | 4.24% | 0.00% |
| Jan. 30, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | Chief Medical Officer | S | Common Stock | 11262 | $15.10 | 97,937.0000 | 0 | 10.31% | 0.00% |
| Jan. 31, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | Chief Medical Officer | S | Common Stock | 1923 | $15.08 | 96,014.0000 | 0 | 1.96% | 0.00% |
| Feb. 1, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | Chief Medical Officer | S | Common Stock | 663 | $15.04 | 95,351.0000 | 0 | 0.69% | 0.00% |
| Jan. 25, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | Chief Medical Officer | S | Common Stock | 1 | $15.00 | 109,199.0000 | 0 | 0.00% | 0.00% |
| Jan. 24, 2024 | NeuroPace Inc | $NPCE | Morrell Martha | Chief Medical Officer | S | Common Stock | 827 | $15.03 | 109,200.0000 | 0 | 0.75% | 0.00% |